Your browser doesn't support javascript.
loading
Regulatory expectations during product development for tumour vaccines.
Kawakami, K; Puri, R K.
Affiliation
  • Kawakami K; Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, CBER, FDA, Bethesda, MD 20892, USA. kawakami@cber.fda.gov
Dev Biol (Basel) ; 116: 53-9; discussion 69-76, 2004.
Article in En | MEDLINE | ID: mdl-15603183
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines Type of study: Prognostic_studies Country/Region as subject: America do norte Language: En Journal: Dev Biol (Basel) Journal subject: ALERGIA E IMUNOLOGIA Year: 2004 Document type: Article Affiliation country: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines Type of study: Prognostic_studies Country/Region as subject: America do norte Language: En Journal: Dev Biol (Basel) Journal subject: ALERGIA E IMUNOLOGIA Year: 2004 Document type: Article Affiliation country: Estados Unidos